This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction.
TouchREVIEWS in endocrinology, 20(2), 62-71
Citation
Qamar, Sulmaaz; Mallik, Ritwika; Makaronidis, Janine. (2024). Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction.. TouchREVIEWS in endocrinology, 20(2), 62-71. https://doi.org/10.17925/EE.2024.20.2.9